InvestorsHub Logo

DragonBear

12/19/14 2:33 PM

#733 RE: lucky, mydog #732

no mention of "subsequent events-they bee screwed

They screwed up in another place...

Company description:

The Company today is in the business of developing, manufacturing and marketing in vitro diagnostic (IVD) tests for over-the-counter (OTC or consumer) and point-of-care (POC or professional) use markets. The Company currently manufactures and markets a range of diagnostic test kits...



And where are the manufacturing facilities located? Who has the out sourcing contract to manufacture the kits? They mention none.

How did an oil company suddenly get into having diagnostic test kits to sell? Ooooh yeah, they bought "Rapid Results". A pretend(?) distributor of the kits. Bought in Jun, with PR pumps about diagnostic kits right up to the suspension. What else did they say about the acquisition:

On June 4, 2014 the Company entered into an agreement to purchase all of the stock of Rapid Result, Inc., an LLC, for $500,000 payable is stock subject to certain conditions. The Company feels those conditions have not been met and have rescinded the agreement. The financials do not include any of the activity of the proposed acquisition.



Oops!!! We have an acquisition of a podunk fly by night distributor of diagnostic kits. Generating PRs out the kazoo in subsequent months, about diagnostic kits being developed, and sold. But they rescinded the agreement after closing back in Jun? In the end the pretend acquisition vaporizing into the mist. Yet the business description pretending they are still manufacturing, and selling diagnostic kits.

Our business plan is focused on expanding in the medical field but we do not anticipate that we will expend any significant funds on research and development.



There's false claims about working with the FDA on new Ebola kits. How does one develop kits out of the thin air with no R&D funding? Or work with the FDA without filing for an IDE?

A bunch of dummies. Nothing like a self hanging in front of the SEC.